SCHEMBL19571007

SCHEMBL19571007

C[C@@H]1CCC[C@H]1OC(N)=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.43
CYP19A1 P11511 1/20 0.41
TSHR P16473 3/20 0.39
ALDH1A1 P00352 2/20 0.39
MAPK1 P28482 2/20 0.39
HTT P42858 2/20 0.39
RAB9A P51151 2/20 0.39
LMNA P02545 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.35
NPC1 O15118 1/20 0.35
TP53 P04637 1/20 0.35
MAPT P10636 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
ATM Q13315 1/20 0.34
HPGD P15428 1/20 0.32
HSD17B10 Q99714 1/20 0.32
METAP2 P50579 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA4 P22748 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10082464 1.00 EPHX1 (0.43) EPHX1CYP19A1TSHRALDH1A1MAPK1
SCHEMBL19570983 1.00 EPHX1 (0.43) EPHX1CYP19A1TSHRALDH1A1MAPK1
SCHEMBL23785933 1.00 EPHX1 (0.43) EPHX1CYP19A1TSHRALDH1A1MAPK1
SCHEMBL19570986 1.00 EPHX1 (0.43) EPHX1CYP19A1TSHRALDH1A1MAPK1
SCHEMBL8431361 0.96 EPHX1 (0.48) EPHX1CYP19A1TSHRALDH1A1MAPK1
SCHEMBL12362878 0.80 CHRM2 (0.47) EPHX1CYP19A1TSHRALDH1A1MAPK1
SCHEMBL12165121 0.80 CHRM2 (0.47) EPHX1CYP19A1TSHRALDH1A1MAPK1
SCHEMBL14962378 0.80 CHRM2 (0.47) EPHX1CYP19A1TSHRALDH1A1MAPK1
SCHEMBL27239806 0.79
SCHEMBL10867518 0.79 SERPINE1 (0.41) EPHX1ATMMETAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3452461-B1 PIPERIDINES AS MENIN INHIBITORS UNIV MICHIGAN REGENTS (US) 2021-09-08 EP disclosed
US-20210198237-A1 PIPERIDINES AS MENIN INHIBITORS UNIV MICHIGAN REGENTS (US) 2021-07-01 US disclosed
WO-2017192543-A1 PIPERIDINES AS MENIN INHIBITORS REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2017-11-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210198237-A1 PIPERIDINES AS MENIN INHIBITORS MEN1, WFS1, BRCA1 EPHX1 3855/4885CYP19A1 1367/4885TSHR 2487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.